New study tracks daily life with rare mast cell disorder
NCT ID NCT07264959
First seen Jun 27, 2026 · Last updated Aug 05, 2026 · Updated 2 times
Summary
This study watches how indolent systemic mastocytosis (ISM) affects people in everyday life. Researchers will collect information on symptoms, treatments, and quality of life from 150 adults. The goal is to better understand the disease and how it is managed, including the use of the drug avapritinib.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INDOLENT SYSTEMIC MASTOCYTOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Brigham and Women's Allergy and Clinical Immunology, Mass General Brigham Healthcare Center (Chestnut Hill)
RECRUITINGChestnut Hill, Massachusetts, 02467, United States
-
Institute for Allergy and Asthma
RECRUITINGWheaton, Maryland, 20902, United States
-
University of Michigan Allergy Clinic
RECRUITINGAnn Arbor, Michigan, 48105, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.